Mezenkimal kök hücrelerin greft enfeksiyonlarında antibakteriyel etkisi: Deneysel bir çalışma

Amaç: Bu çalışmada, sıçan modelinde, tigesikline kıyasla, mezenkimal kök hücrelerin metisiline dirençli Staphylococcus epidermidis ile ilişkili greft enfeksiyonu üzerindeki antibakteriyel etkileri araştırıldı. Ça­lış­ma pla­nı: Toplam 42 erkek erişkin Wistar cinsi sıçan (yaş >6 ay; ağırlık 300-350 g) her grupta yedi sıçan olacak şekilde altı gruba ayrıldı. Grup 0 herhangi bir prosedürden geçmedi; Grup 1 enfekte edildi, ancak tedavi edilmedi; Grup 2 enfekte edildi ve greft yerleştirilmeden tigesiklin ile tedavi edildi; Grup 3 enfekte edildi ve greft yerleştirilmeden mezenkimal kök hücre ile tedavi edildi; Grup 4 greft yerleştirildikten sonra enfekte edildi ve tigesiklin ile tedavi edildi; Grup 5 greft yerleştirildikten sonra enfekte edildi ve mezenkimal kök hücre ile tedavi edildi. Oluşturulan cepler boş bırakıldı veya Dacron greftle implante edildi. Tedaviye 48 saat sonra başlandı. Numuneler 13. günde toplandı. Perigreft dokular histopatolojik olarak değerlendirildi ve bakteri koloni sayıları tespit edildi. Bulgular: Grup 0'da bakteri kolonizasyonu gözlenmez iken, Grup 1'de belirgin kolonizasyon görüldü. Grup 2 ve Grup 3'te (greftsiz gruplar) tam eradikasyon sağlandı ve Grup 4 ve Grup 5'te (greft yerleştirilen gruplar) tama yakın eradikasyon elde edildi. Histopatolojik bulgular açısından Grup 1-Grup 2 ve Grup 1-Grup 3 arasında (greftsiz gruplar) anlamlı bir fark vardı. Histopatolojik bulgular Grup 2-Grup 3 ve Grup 4-Grup 5 arasında benzerdi. So­nuç: Çalışma sonuçlarımız, mezenkimal kök hücrelerin antibiyotik tedavisine yeni ve modern bir alternatif olabileceğini ve enfekte greft alanlarında Staphylococcus’un biyoyükünü azaltabileceğini ve mezenkimal kök hücre tedavisinin tigesiklin kadar etkili olabileceğini göstermektedir.

The antibacterial effect of mesenchymal stem cells on graft infections: An experimental study

Background: In this study, we aimed to investigate the antibacterialeffects of mesenchymal stem cells, compared to tigecycline, on graftinfection related with methicillin-resistant Staphylococcus epidermidisin a rat model.Methods: A total of 42 male adult Wistar rats (age >6 months; weight300 to 350 g) were divided into six groups including seven rats in each.Group 0 did not undergo any procedure; Group 1 was infected, butuntreated; Group 2 was infected and treated with tigecycline withoutgraft placement; Group 3 was infected and received mesenchymal stemcells without graft placement; Group 4 was infected and treated withtigecycline after graft placement; Group 5 was infected and treatedwith mesenchymal stem cells after graft placement. The pocketscreated were either left empty or implanted with Dacron grafts.Treatment was commenced at 48 h. Specimens were collected on Day13. Perigraft tissues were evaluated histopathologically and bacterialcolony numbers were counted.Results: No bacterial colonization was observed in Group 0, whereasthere was a significant colonization in Group 1. Complete eradicationwas achieved in Group 2 and Group 3 (graft-free groups), andnear-complete eradication was achieved in Group 4 and Group 5(graft-implanted groups). The histopathological findings significantlydiffered between Group 1-Group 2 and between Group 1-Group3 (graft-free groups). The histopathological findings were similarbetween Group 2-Group 3 and between Group 4-Group 5.Conclusion: Our study results suggest that mesenchymal stem cellsmay be a novel, contemporary alternative to antibiotherapy and maydecrease the bio-burden of Staphylococcus at the infected graftareas, and mesenchymal stem cell treatment may be as effective astigecycline.

___

  • Yang SY, Strong N, Gong X, Heggeness MH. Differentiation of nerve-derived adult pluripotent stem cells into osteoblastic and endothelial cells. Spine J 2017;17:277-81.
  • Bakre MM, Hoi A, Mong JC, Koh YY, Wong KY, Stanton LW. Generation of multipotential mesendodermal progenitors from mouse embryonic stem cells via sustained Wnt pathway activation. Biol Chem 2007;282:31703-12.
  • Alcayaga-Miranda F, Cuenca J, Martin A, Contreras L, Figueroa FE, Khoury M, et al. Combination therapy of menstrual derived mesenchymal stem cells and antibiotics ameliorates survival in sepsis. Stem Cell Res Ther 2015;6:199.
  • Ma S, Xie N, Li W, Yuan B, Shi Y, Wang Y. Immunobiology of mesenchymal stem cells. Cell Death Differ 2014;21:216-25.
  • Sutton MT, Fletcher D, Ghosh SK, Weinberg A, van Heeckeren R, Kaur S, et al. Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment. Stem Cells Int 2016;2016:5303048.
  • Sung DK, Chang YS, Sung SI, Yoo HS, Ahn SY, Park WS. Antibacterial effect of mesenchymal stem cells against Escherichia coli is mediated by secretion of beta- defensin2 via toll- like receptor 4 signalling. Cell Microbiol. 2016;18:424-36.
  • Murphy K, Weaver C. Janeway's immunobiology. 9th ed. New York: Garland Science 2016.
  • Revest M, Camou F, Senneville E, Caillon J, Laurent F, Calvet B, et al. Medical treatment of prosthetic vascular graft infections: Review of the literature and proposals of a Working Group. Int J Antimicrob Agents 2015;46:254-65.
  • Romanò CL, Manzi G, Logoluso N, Romanò D. Value of debridement and irrigation for the treatment of peri-prosthetic infections. A systematic review. Hip Int 2012;22:19-24.
  • Gardete S, Tomasz A. Mechanisms of vancomycin resistance in Staphylococcus aureus. J Clin Invest 2014;124:2836-40.
  • Yasim A, Gul M, Ciralik H, Ergun Y. Gelatin-sealed dacron graft is not more susceptible to MRSA infection than PTFE graft. Eur J Vasc Endovasc Surg 2006;32:425-30.
  • Aybar Y, Ozaras R, Besirli K, Engin E, Karabulut E, Salihoglu T, et al. Efficacy of tigecycline and vancomycin in experimental catheter-related Staphylococcus epidermidis infection: microbiological and electron microscopic analysis of biofilm. Int J Antimicrob Agents 2012;39:338-42.
  • Drew WL, Barry AL, O’Toole R, Sherris JC. Reliability of the Kirby-Bauer disc diffusion method for detecting methicillin-resistant strains of Staphylococcus aureus. Appl Microbiol 1972;24:240-7.
  • Goessens WH, Mouton JW, Ten Kate MT, Sörgel F, Kinzig M, Bakker-Woudenberg IA. The therapeutic effect of tigecycline, unlike that of Ceftazidime, is not influenced by whether the Klebsiella pneumoniae strain produces extended-spectrum b-lactamases in experimental pneumonia in rats. Antimicrob Agents Chemother 2013;57:643-6.
  • Nagaya N, Kangawa K, Itoh T, Iwase T, Murakami S, Miyahara Y, e.t al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 2005;112:1128-35.
  • Ozturk B, Kurtoglu T, Durmaz S, Kozaci LD, Abacigil F, Ertugrul B, et al. The effects of ozone on bacterial growth and thiol-disulphide homeostasis in vascular graft infection caused by MRSA in rats. Acta Cir Bras 2017;32:219-28.
  • Hernández-Richter T, Schardey HM, Wittmann F, Mayr S, Schmitt-Sody M, Blasenbreu S, et al. Rifampin and Triclosan but not silver is effective in preventing bacterial infection of vascular dacron graft material. Eur J Vasc Endovasc Surg 2003;26:550-7.
  • Fysaraki M, Samonis G, Valachis A, Daphnis E, Karageorgopoulos DE, Falagas ME, et al. Incidence, clinical, microbiological features and outcome of bloodstream infections in patients undergoing hemodialysis. Int J Med Sci 2013;10:1632-8.
  • Murphy EH, Szeto WY, Herdrich BJ, Jackson BM, Wang GJ, Bavaria JE, et al. The management of endograft infections following endovascular thoracic and abdominal aneurysm repair. J Vasc Surg 2013;58:1179-85.
  • Pajarinen J, Lin T, Gibon E, Kohno Y, Maruyama M, Nathan K, et al. Mesenchymal stem cell-macrophage crosstalk and bone healing. Biomaterials. 2018 Jan 2.
  • Gong L, Zhao Y, Zhang Y, Ruan Z. The Macrophage Polarization Regulates MSC Osteoblast Differentiation in vitro. Ann Clin Lab Sci 2016;46:65-71.
  • Maranda EL, Rodriguez-Menocal L, Badiavas EV. Role of Mesenchymal Stem Cells in Dermal Repair in Burns and Diabetic Wounds. Curr Stem Cell Res Ther 2017;12:61-70.
  • Turksen K, editor. Wound Healing: Stem Cells Repair and Restorations, Basic and Clinical Aspects. Hoboken, NJ: John Wiley & Sons; 2017. p. 44-52.
  • Manner S, Goeres DM, Skogman M, Vuorela P, Fallarero A. Prevention of Staphylococcus aureus biofilm formation by antibiotics in 96-Microtiter Well Plates and Drip Flow Reactors: critical factors influencing outcomes. Sci Rep 2017;7:43854.
  • Bozoglan O, Mese B, Eroglu E, Elveren S, Gul M, Celik A, et al. Which prosthesis is more resistant to vascular graft infection: polytetrafluoroethylene or Omniflow II biosynthetic grafts? Surg Today 2016;46:363-70.
  • Wozniak W, Kozinska A, Ciostek P, Sitkiewicz I. Susceptibility of Vascular Implants to Colonization in vitro by Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus faecalis and Pseudomonas aeruginosa. Pol J Microbiol 2017;66:125-9.
  • Meisel R, Brockers S, Heseler K, Degistirici O, Bülle H, Woite C, et al. Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase. Leukemia 2011;25:648-54.
  • Guerra AD, Cantu DA, Vecchi JT, Rose WE, Hematti P, Kao WJ. Mesenchymal Stromal/Stem Cell and MinocyclineLoaded Hydrogels Inhibit the Growth of Staphylococcus aureus that Evades Immunomodulation of Blood-Derived Leukocytes. AAPS J 2015;17:620-30.
  • Uccelli A, de Rosbo NK. The immunomodulatory function of mesenchymal stem cells: mode of action and pathways. Ann N Y Acad Sci 2015;1351:114-26.
  • Qian J, Hu Y, Zhao L, Xia J, Li C, Shi L, et al. Protective Role of Adipose-Derived Stem Cells in Staphylococcus aureusInduced Lung Injury is Mediated by RegIIIg Secretion. Stem Cells 2016;34:1947-56.
Türk Göğüs Kalp Damar Cerrahisi Dergisi-Cover
  • ISSN: 1301-5680
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 1991
  • Yayıncı: Bayçınar Tıbbi Yayıncılık
Sayıdaki Diğer Makaleler

Akciğer adenokarsinomlu bir hastada eş zamanlı atan kalpte koroner arter baypas greftleme ve sağ üst lobektomi

Ferit ÇİÇEKÇİOĞLU, Zafer Cengiz ER, Kıvanç ATILGAN, Ertan DEMİRDAŞ, Bayram METİN

Bleomisin ile indüklenmiş pulmoner fibroziste sistenil lökotrien reseptör antagonisti montelukastın koruyucu etkisi

Tunç LAÇİN, Emine BOZKURTLAR, Göksel ŞENER, Berrin CEYHAN, Şehnaz OLGUN YILDIZELİ, Çiğdem ÇELİKEL, Özer ŞEHİRLİ, Nurhayat TOPALOĞLU

Koroner arter baypas greftleme yapılan hastalarda öz bakım girişimlerinin uyku kalitesi üzerine etkisi: Tek merkezli, randomize kontrollü çalışma

Haleh GHAVAMİ, Rasoul Ghare Aghaji ASL, Fahimeh SAFARZADEH

Dışarıdan tamamen görülebilen perikardiyumu olan bir hastada dev torasik defektin kapanması için negatif basınçlı yara kapama sistemi: Olgu sunumu

Orhan KOZAK, Mustafa Tahir ÖZER, Sedat GÜRKOK, Şahin KAYMAK, Hüseyin SİNAN, Ersin SAPMAZ

Senning ameliyatı sonrası geç dönem pulmoner venöz odacık darlığının cerrahi tedavisi

Yüksel ATAY, Çağatay BİLEN, Gökmen AKKAYA, Osman Nuri TUNCER, Mehmet Fatih AYIK

Tekrarlayan hızlı homogreft dejenerasyonu ve yaygın kalsifikasyonu

Muhammet AKYÜZ, Ali Rahmi BAKİLER, Onur IŞIK, Fulya KAMİT CAN

Aort anevrizması ve aort diseksiyonu gelişiminin genetik faktörler ile ilişkisi

Ömer Naci EMİROĞULLARI, Aydın TUNÇAY, Elif Funda ŞENER, Rıfat ÖZMEN

Koroner arter bypass cerrahisi sonrası erken dönemde aspirin direnci gelişme sıklığı ve tromboksan A2 üretiminin yetersiz inhibisyonu

Filiz ALKAYA SOLMAZ, Kenan Abdurrahman KARA, İlker KİRİŞ, Hayrettin ÖZKAN, Hüseyin OKUTAN, Şenol GÜLMEN

Akciğer naklinde proantosiyanidinin iskemi-reperfüzyon hasarını önleyici etkisinin araştırılması: Deneysel çalışma

Mehmet GAMSIZKAN, Onur GENÇ, Kuthan KAVAKLI, Yusuf Sinan ŞİRİN, Hasan ÇAYLAK, Ersin SAPMAZ

Bilateral internal iliyak arter hastalığı ve kalça klodikasyonu olan hastalarda endovasküler tedavi

Burak TEYMEN, Mehmet ÖZKAN